TY - JOUR AU - Chung, C. P. AU - Oeser, A. AU - Raggi, P. AU - Gebretsadik, T. AU - Shintani, A. K. AU - Sokka, T. AU - Pincus, T. AU - Avalos, I. AU - Stein, C. M. PY - 2005 DA - 2005// TI - Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21288 DO - 10.1002/art.21288 ID - Chung2005 ER - TY - JOUR AU - Chung, C. P. AU - Oeser, A. AU - Solus, J. F. AU - Avalos, I. AU - Gebretsadik, T. AU - Shintani, A. AU - Raggi, P. AU - Sokka, T. AU - Pincus, T. AU - Stein, C. M. PY - 2008 DA - 2008// TI - Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis JO - Atherosclerosis VL - 196 UR - https://doi.org/10.1016/j.atherosclerosis.2007.01.004 DO - 10.1016/j.atherosclerosis.2007.01.004 ID - Chung2008 ER - TY - JOUR AU - Chung, C. P. AU - Oeser, A. AU - Solus, J. F. AU - Gebretsadik, T. AU - Shintani, A. AU - Avalos, I. AU - Sokka, T. AU - Raggi, P. AU - Pincus, T. AU - Stein, C. M. PY - 2008 DA - 2008// TI - Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23600 DO - 10.1002/art.23600 ID - Chung2008 ER - TY - JOUR AU - McMillan, D. E. PY - 1989 DA - 1989// TI - Increased levels of acute-phase serum proteins in diabetes JO - Metabolism VL - 38 UR - https://doi.org/10.1016/0026-0495(89)90038-3 DO - 10.1016/0026-0495(89)90038-3 ID - McMillan1989 ER - TY - JOUR AU - Katsuki, A. AU - Sumida, Y. AU - Murashima, S. AU - Murata, K. AU - Takarada, Y. AU - Ito, K. AU - Fujii, M. AU - Tsuchihashi, K. AU - Goto, H. AU - Nakatani, K. AU - Yano, Y. PY - 1998 DA - 1998// TI - Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus JO - J Clin Endocrinol Metab VL - 83 ID - Katsuki1998 ER - TY - JOUR AU - Festa, A. AU - D’Agostino, R. AU - Howard, G. AU - Mykkänen, L. AU - Tracy, R. P. AU - Haffner, S. M. PY - 2000 DA - 2000// TI - Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.1.42 DO - 10.1161/01.CIR.102.1.42 ID - Festa2000 ER - TY - JOUR AU - Pickup, J. C. AU - Mattock, M. B. AU - Chusney, G. D. AU - Burt, D. PY - 1997 DA - 1997// TI - NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X JO - Diabetologia VL - 40 UR - https://doi.org/10.1007/s001250050822 DO - 10.1007/s001250050822 ID - Pickup1997 ER - TY - JOUR AU - Fernandez-Real, J. M. AU - Vayreda, M. AU - Richart, C. AU - Gutierrez, C. AU - Broch, M. AU - Vendrell, J. AU - Ricart, W. PY - 2001 DA - 2001// TI - Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women JO - J Clin Endocrinol Metab VL - 86 UR - https://doi.org/10.1210/jcem.86.3.7305 DO - 10.1210/jcem.86.3.7305 ID - Fernandez-Real2001 ER - TY - JOUR AU - Arkan, M. C. AU - Hevener, A. L. AU - Greten, F. R. AU - Maeda, S. AU - Li, Z. W. AU - Long, J. M. AU - Wynshaw-Boris, A. AU - Poli, G. AU - Olefsky, J. AU - Karin, M. PY - 2005 DA - 2005// TI - IKK-β links inflammation to obesity-induced insulin resistance JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1185 DO - 10.1038/nm1185 ID - Arkan2005 ER - TY - JOUR AU - Romeo, G. R. AU - Lee, J. AU - Shoelson, S. E. PY - 2012 DA - 2012// TI - Metabolic syndrome, insulin resistance, and roles of inflammation–mechanisms and therapeutic targets JO - Arterioscler Thromb Vasc Biol VL - 32 UR - https://doi.org/10.1161/ATVBAHA.111.241869 DO - 10.1161/ATVBAHA.111.241869 ID - Romeo2012 ER - TY - JOUR AU - Stagakis, I. AU - Bertsias, G. AU - Karvounaris, S. AU - Kavousanaki, M. AU - Virla, D. AU - Raptopoulou, A. AU - Kardassis, D. AU - Boumpas, D. T. AU - Sidiropoulos, P. I. PY - 2012 DA - 2012// TI - Anti-tumor necrosis factor therapy improves insulin resistance, β cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance JO - Arthritis Res Ther VL - 14 UR - https://doi.org/10.1186/ar3874 DO - 10.1186/ar3874 ID - Stagakis2012 ER - TY - JOUR AU - Feingold, K. R. AU - Soued, M. AU - Staprans, I. AU - Gavin, L. A. AU - Donahue, M. E. AU - Huang, B. J. AU - Moser, A. H. AU - Gulli, R. AU - Grunfeld, C. PY - 1989 DA - 1989// TI - Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat: evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia JO - J Clin Invest VL - 83 UR - https://doi.org/10.1172/JCI113991 DO - 10.1172/JCI113991 ID - Feingold1989 ER - TY - JOUR AU - Hotamisligil, G. S. AU - Shargill, N. S. AU - Spiegelman, B. M. PY - 1993 DA - 1993// TI - Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance JO - Science VL - 259 UR - https://doi.org/10.1126/science.7678183 DO - 10.1126/science.7678183 ID - Hotamisligil1993 ER - TY - JOUR AU - Svenson, K. L. AU - Lundqvist, G. AU - Wide, L. AU - Hällgren, R. PY - 1987 DA - 1987// TI - Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones JO - Metabolism VL - 36 UR - https://doi.org/10.1016/0026-0495(87)90128-4 DO - 10.1016/0026-0495(87)90128-4 ID - Svenson1987 ER - TY - JOUR AU - Morohoshi, M. AU - Fujisawa, K. AU - Uchimura, I. AU - Numano, F. PY - 1996 DA - 1996// TI - Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro JO - Diabetes VL - 45 UR - https://doi.org/10.2337/diab.45.7.954 DO - 10.2337/diab.45.7.954 ID - Morohoshi1996 ER - TY - JOUR AU - Renier, G. AU - Clément, I. AU - Desfaits, A. C. AU - Lambert, A. PY - 1996 DA - 1996// TI - Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-α production JO - Endocrinology VL - 137 ID - Renier1996 ER - TY - JOUR AU - Soop, M. AU - Duxbury, H. AU - Agwunobi, A. O. AU - Gibson, J. M. AU - Hopkins, S. J. AU - Childs, C. AU - Cooper, R. G. AU - Maycock, P. AU - Little, R. A. AU - Carlson, G. L. PY - 2002 DA - 2002// TI - Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans JO - Am J Physiol Endocrinol Metab VL - 282 UR - https://doi.org/10.1152/ajpendo.00535.2001 DO - 10.1152/ajpendo.00535.2001 ID - Soop2002 ER - TY - JOUR AU - Kim, S. G. AU - Ryu, O. H. AU - Kim, H. Y. AU - Lee, K. W. AU - Seo, J. A. AU - Kim, N. H. AU - Choi, K. M. AU - Lee, J. AU - Baik, S. H. AU - Choi, D. S. PY - 2006 DA - 2006// TI - Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome JO - Eur J Endocrinol VL - 154 UR - https://doi.org/10.1530/eje.1.02100 DO - 10.1530/eje.1.02100 ID - Kim2006 ER - TY - JOUR AU - Aljada, A. AU - Garg, R. AU - Ghanim, H. AU - Mohanty, P. AU - Hamouda, W. AU - Assian, E. AU - Dandona, P. PY - 2001 DA - 2001// TI - Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? JO - J Clin Endocrinol Metab VL - 86 ID - Aljada2001 ER - TY - JOUR AU - Mohanty, P. AU - Aljada, A. AU - Ghanim, H. AU - Hofmeyer, D. AU - Tripathy, D. AU - Syed, T. AU - Al-Haddad, W. AU - Dhindsa, S. AU - Dandona, P. PY - 2004 DA - 2004// TI - Evidence for a potent antiinflammatory effect of rosiglitazone JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-032103 DO - 10.1210/jc.2003-032103 ID - Mohanty2004 ER - TY - JOUR AU - Ghanim, H. AU - Dhindsa, S. AU - Aljada, A. AU - Chaudhuri, A. AU - Viswanathan, P. AU - Dandona, P. PY - 2006 DA - 2006// TI - Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics JO - J Clin Endocrinol Metab VL - 91 UR - https://doi.org/10.1210/jc.2005-2609 DO - 10.1210/jc.2005-2609 ID - Ghanim2006 ER - TY - JOUR AU - Miyazaki, Y. AU - DeFronzo, R. A. PY - 2008 DA - 2008// TI - Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients JO - Diabetes Obes Metab VL - 10 ID - Miyazaki2008 ER - TY - JOUR AU - Koufany, M. AU - Moulin, D. AU - Bianchi, A. AU - Muresan, M. AU - Sebillaud, S. AU - Netter, P. AU - Weryha, G. AU - Jouzeau, J. Y. PY - 2008 DA - 2008// TI - Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis JO - Arthritis Res Ther VL - 10 UR - https://doi.org/10.1186/ar2354 DO - 10.1186/ar2354 ID - Koufany2008 ER - TY - JOUR AU - Cuzzocrea, S. AU - Mazzon, E. AU - Dugo, L. AU - Patel, N. S. AU - Serraino, I. AU - Di Paola, R. AU - Genovese, T. AU - Britti, D. AU - De Maio, M. AU - Caputi, A. P. AU - Thiemermann, C. PY - 2003 DA - 2003// TI - Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor γ JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11351 DO - 10.1002/art.11351 ID - Cuzzocrea2003 ER - TY - JOUR AU - Shahin, D. AU - Toraby, E. E. AU - Abdel-Malek, H. AU - Boshra, V. AU - Elsamanoudy, A. Z. AU - Shaheen, D. PY - 2011 DA - 2011// TI - Effect of peroxisome proliferator-activated receptor γ agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study) JO - Clin Med Insights Arthritis Musculoskelet Disord VL - 4 UR - https://doi.org/10.4137/CMAMD.S5951 DO - 10.4137/CMAMD.S5951 ID - Shahin2011 ER - TY - JOUR AU - Bongartz, T. AU - Coras, B. AU - Vogt, T. AU - Schölmerich, J. AU - Müller-Ladner, U. PY - 2005 DA - 2005// TI - Treatment of active psoriatic arthritis with the PPARγ ligand pioglitazone: an open-label pilot study JO - Rheumatology (Oxford) VL - 44 UR - https://doi.org/10.1093/rheumatology/keh423 DO - 10.1093/rheumatology/keh423 ID - Bongartz2005 ER - TY - JOUR AU - Juárez-Rojas, J. G. AU - Medina-Urrutia, A. X. AU - Jorge-Galarza, E. AU - Caracas-Portilla, N. A. AU - Posadas-Sánchez, R. AU - Cardoso-Saldaña, G. C. AU - Goycochea-Robles, M. V. AU - Silveira, L. H. AU - Lino-Pérez, L. AU - Mas-Oliva, J. AU - Pérez-Méndez, O. AU - Posadas-Romero, C. PY - 2012 DA - 2012// TI - Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial JO - Lupus VL - 21 UR - https://doi.org/10.1177/0961203311422096 DO - 10.1177/0961203311422096 ID - Juárez-Rojas2012 ER - TY - JOUR AU - McCoy, R. G. AU - Irving, B. A. AU - Soop, M. AU - Srinivasan, M. AU - Tatpati, L. AU - Chow, L. AU - Weymiller, A. J. AU - Carter, R. E. AU - Nair, K. S. PY - 2012 DA - 2012// TI - Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance JO - Mayo Clin Proc VL - 87 UR - https://doi.org/10.1016/j.mayocp.2012.02.014 DO - 10.1016/j.mayocp.2012.02.014 ID - McCoy2012 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. AU - Healey, L. A. AU - Kaplan, S. R. AU - Liang, M. H. AU - Luthra, H. S. AU - Medsger, T. A. AU - Mitchell, D. M. AU - Neustadt, D. H. AU - Pinals, R. S. AU - Jane, G. AU - Schaller, J. G. AU - Sharp, J. T. AU - Wilder, R. L. AU - Hunder, G. G. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - STD TI - European Medicines Agency: European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer: benefit-risk balance remains positive in a limited population of type 2 diabetics. Press Release EMA/CHMP/568262/2011). London: Author; 21 July 2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/07/WC500109176.pdf (accessed 13 September 2013) UR - http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/07/WC500109176.pdf ID - ref30 ER - TY - STD TI - US Food and Drug Administration (FDA): FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer. Safety Announcement). Silver Spring, MD: Author; 15 June 2011. Available at http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm (accessed 13 September 2013 UR - http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm ID - ref31 ER - TY - JOUR AU - Pincus, T. AU - Summey, J. A. AU - Soraci, S. A. AU - Wallston, K. A. AU - Hummon, N. P. PY - 1983 DA - 1983// TI - Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire JO - Arthritis Rheum VL - 26 UR - https://doi.org/10.1002/art.1780261107 DO - 10.1002/art.1780261107 ID - Pincus1983 ER - TY - JOUR AU - Matthews, D. R. AU - Hosker, J. P. AU - Rudenski, A. S. AU - Naylor, B. A. AU - Treacher, D. F. AU - Turner, R. C. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - McCarey, D. W. AU - McInnes, I. B. AU - Madhok, R. AU - Hampson, R. AU - Scherbakov, O. AU - Ford, I. AU - Capell, H. A. AU - Sattar, N. PY - 2004 DA - 2004// TI - Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16449-0 DO - 10.1016/S0140-6736(04)16449-0 ID - McCarey2004 ER - TY - JOUR AU - Maini, R. N. AU - Taylor, P. C. AU - Szechinski, J. AU - Pavelka, K. AU - Bröll, J. AU - Balint, G. AU - Emery, P. AU - Raemen, F. AU - Petersen, J. AU - Smolen, J. AU - Thomson, D. AU - Kishimoto, T. PY - 2006 DA - 2006// TI - Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22033 DO - 10.1002/art.22033 ID - Maini2006 ER - TY - JOUR AU - Baron, R. M. AU - Kenny, D. A. PY - 1986 DA - 1986// TI - The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations JO - J Pers Soc Psychol VL - 51 UR - https://doi.org/10.1037/0022-3514.51.6.1173 DO - 10.1037/0022-3514.51.6.1173 ID - Baron1986 ER - TY - JOUR AU - Palma, A. AU - Sainaghi, P. P. AU - Amoruso, A. AU - Fresu, L. G. AU - Avanzi, G. AU - Pirisi, M. AU - Brunelleschi, S. PY - 2012 DA - 2012// TI - Peroxisome proliferator-activated receptor-γ expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy––a pilot study JO - Rheumatology (Oxford) VL - 51 UR - https://doi.org/10.1093/rheumatology/kes177 DO - 10.1093/rheumatology/kes177 ID - Palma2012 ER - TY - JOUR AU - Pepys, M. B. AU - Hirschfield, G. M. PY - 2003 DA - 2003// TI - C-reactive protein: a critical update JO - J Clin Invest VL - 111 UR - https://doi.org/10.1172/JCI200318921 DO - 10.1172/JCI200318921 ID - Pepys2003 ER - TY - JOUR AU - Shedlovsky, T. AU - Scudder, J. PY - 1942 DA - 1942// TI - A comparison of erythrocyte sedimentation rates and electrophoretic patterns of normal and pathological human blood JO - J Exp Med VL - 75 UR - https://doi.org/10.1084/jem.75.1.119 DO - 10.1084/jem.75.1.119 ID - Shedlovsky1942 ER - TY - JOUR AU - Reinhart, W. H. AU - Singh, A. AU - Straub, P. W. PY - 1989 DA - 1989// TI - Red blood cell aggregation and sedimentation: the role of the cell shape JO - Br J Haematol VL - 73 UR - https://doi.org/10.1111/j.1365-2141.1989.tb00296.x DO - 10.1111/j.1365-2141.1989.tb00296.x ID - Reinhart1989 ER - TY - JOUR AU - Staniloae, C. AU - Mandadi, V. AU - Kurian, D. AU - Coppola, J. AU - Bernaski, E. AU - El-Khally, Z. AU - Morlote, M. AU - Pinassi, E. AU - Ambrose, J. PY - 2007 DA - 2007// TI - Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease JO - Cardiology VL - 108 UR - https://doi.org/10.1159/000096601 DO - 10.1159/000096601 ID - Staniloae2007 ER - TY - JOUR AU - Sarafidis, P. A. AU - Lasaridis, A. N. AU - Nilsson, P. M. AU - Mouslech, T. F. AU - Hitoglou-Makedou, A. D. AU - Stafylas, P. C. AU - Kazakos, K. A. AU - Yovos, J. G. AU - Tourkantonis, A. A. PY - 2005 DA - 2005// TI - The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension: an open-label observational study JO - Metabolism VL - 54 UR - https://doi.org/10.1016/j.metabol.2005.04.010 DO - 10.1016/j.metabol.2005.04.010 ID - Sarafidis2005 ER - TY - JOUR AU - Schöndorf, T. AU - Lübben, G. AU - Hoopmann, M. AU - Borchert, M. AU - Forst, T. AU - Hohberg, C. AU - Löbig, M. AU - Armbruster, F. P. AU - Roth, W. AU - Grabellus, M. AU - Pfützner, A. PY - 2007 DA - 2007// TI - Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus JO - Gynecol Endocrinol VL - 23 UR - https://doi.org/10.1080/09513590701447998 DO - 10.1080/09513590701447998 ID - Schöndorf2007 ER - TY - JOUR AU - Aubert, R. E. AU - Herrera, V. AU - Chen, W. AU - Haffner, S. M. AU - Pendergrass, M. PY - 2010 DA - 2010// TI - Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes JO - Diabetes Obes Metab VL - 12 UR - https://doi.org/10.1111/j.1463-1326.2010.01225.x DO - 10.1111/j.1463-1326.2010.01225.x ID - Aubert2010 ER - TY - JOUR AU - Azoulay, L. AU - Yin, H. AU - Filion, K. B. AU - Assayaq, J. AU - Majdan, A. AU - Pollak, M. N. AU - Suissa, S. PY - 2012 DA - 2012// TI - The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case–control study JO - BMJ VL - 344 UR - https://doi.org/10.1136/bmj.e3645 DO - 10.1136/bmj.e3645 ID - Azoulay2012 ER - TY - JOUR AU - Lincoff, A. M. AU - Wolski, K. AU - Nicholls, S. J. AU - Nissen, S. E. PY - 2007 DA - 2007// TI - Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.10.1180 DO - 10.1001/jama.298.10.1180 ID - Lincoff2007 ER - TY - JOUR AU - Hetzel, J. AU - Balletshofer, B. AU - Rittig, K. AU - Walcher, D. AU - Kratzer, W. AU - Hombach, V. AU - Häring, H. U. AU - Koenig, W. AU - Marx, N. PY - 2005 DA - 2005// TI - Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers JO - Arterioscler Thromb Vasc Biol VL - 25 UR - https://doi.org/10.1161/01.ATV.0000176192.16951.9a DO - 10.1161/01.ATV.0000176192.16951.9a ID - Hetzel2005 ER - TY - JOUR AU - Yki-Järvinen, H. PY - 2004 DA - 2004// TI - Thiazolidinediones JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMra041001 DO - 10.1056/NEJMra041001 ID - Yki-Järvinen2004 ER - TY - JOUR AU - Guri, A. J. AU - Mohapatra, S. K. AU - Horne, W. T. AU - Hontecillas, R. AU - Bassaganya-Riera, J. PY - 2010 DA - 2010// TI - The role of T cell PPAR γ in mice with experimental inflammatory bowel disease JO - BMC Gastroenterol VL - 10 UR - https://doi.org/10.1186/1471-230X-10-60 DO - 10.1186/1471-230X-10-60 ID - Guri2010 ER - TY - JOUR AU - Jiang, C. AU - Ting, A. T. AU - Seed, B. PY - 1998 DA - 1998// TI - PPAR-γ agonists inhibit production of monocyte inflammatory cytokines JO - Nature VL - 391 UR - https://doi.org/10.1038/35154 DO - 10.1038/35154 ID - Jiang1998 ER - TY - JOUR AU - Bright, J. J. AU - Kanakasabai, S. AU - Chearwae, W. AU - Chakraborty, S. PY - 2008 DA - 2008// TI - PPAR regulation of inflammatory signaling in CNS diseases JO - PPAR Res VL - 2008 UR - https://doi.org/10.1155/2008/658520 DO - 10.1155/2008/658520 ID - Bright2008 ER -